Home/Filings/4/0001671617-16-000002
4//SEC Filing

Immune Therapeutics, Inc. 4

Accession 0001671617-16-000002

CIK 0001559356operating

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 3:35 PM ET

Size

5.0 KB

Accession

0001671617-16-000002

Insider Transaction Report

Form 4
Period: 2016-04-08
Transactions
  • Other

    COMMON STOCK

    2016-04-08+250,000250,000 total(indirect: By LLC)
Footnotes (2)
  • [F1]The shares were issued pursuant to a compensation agreement as a director of the company. The cost-basis is the market price on the day of issuance of $0.14
  • [F2]The shares were issued directly to Selsky Consulting, LLC which is owned 100% by the reporting person.

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001559356

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 3:35 PM ET
Size
5.0 KB